Join Team Norway at Swiss Nordic Bio 2025
13.03.2025
Conference
Swiss Nordic Bio serves as the top platform for bringing together life science professionals from Switzerland and the Nordic countries in one place, fostering collaboration and investment opportunities across borders.
Join us in Zurich on 13 March 2025 and be a part of this exclusive gathering. Swiss Nordic Bio 2025 is your gateway to forging strong partnerships and advancing the future of life sciences across Europe.
This conference is organised by the Nordic countries, in partnership with Swiss stakeholders, to facilitate meaningful connections and promote the growth of life sciences. Swiss Nordic Bio 2025 offers a unique space for biotech start-ups, pharmaceutical companies, investors, and research institutions to exchange insights, explore new partnerships, and engage in valuable networking.
Why attend Swiss Bio 2025
- Networking Across Borders: Meet leading life science professionals from Switzerland and the Nordic countries, all in one location.
- Partnering Opportunities: Engage in strategic one-on-one meetings to find investment and collaboration opportunities.
- Exclusive Insights: Learn from experts in healthcare innovation and gain new perspectives on industry trends and developments.
Practical information
For more information about potential partnerships or collaborations, please email us.
Important conditions
Companies must adhere to standards for responsible business conduct, including Environmental, Social, and Governance (ESG) criteria.
Participants are expected to operate in accordance with the UN Guiding Principles on Business and Human Rights and the OECD Guidelines for Multinational Enterprises on Responsible Business Conduct. This entails conducting business responsibly, respecting human rights, ensuring decent working conditions, safeguarding environmental considerations, and actively preventing corruption.
Companies must carry out their own due diligence assessments (risk assessments) to identify, prevent, and mitigate potential adverse impacts.